August 5, 2026 | 5:00 PM - 5:45 PM ET | Virtual Livestream; OnDemand to follow
Congestion in chronic heart failure is commonly treated with loop diuretics such as furosemide. Although intravenous administration is effective, it often requires clinic visits or hospitalization. Join HFSA's Cardio Abstract event to review new data on a novel 80 mg/mL subcutaneous furosemide formulation delivered in a single 1.0-mL injection, offering a potentially more convenient treatment option for patients.
Faculty
Speaker: Tamas Alexy, MD, PhD, FHFSA
The University of Minnesota Medical School (Cardiovascular Division)
Speaker: John Mohr, PharmD
VaultBio
Speaker: James Udelson, MD
Tufts Medical Center Cardiovascular Center